Cook Zilver goes global
This article was originally published in The Gray Sheet
Executive Summary
Paclitaxel-eluting peripheral stent safety and efficacy to be studied in 760-patient, 50-site trial in Europe, Asia, Australia and Canada. Enrollment for a 60-patient pilot trial, which could be converted to a pivotal study to support a PMA for the Zilver PTX stent for femoropopliteal arteries above the knee, is ongoing in the U.S. (1"The Gray Sheet" Feb. 14, 2005, p. 27)...